Patents by Inventor Yu Chuan Huang

Yu Chuan Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240277865
    Abstract: Disclosed herein is a phage-displayed single-chain variable fragment (scFv) library, which comprises a plurality of phage-displayed scFvs characterized with a specific sequence in each CDR. The present phage-displayed scFv library is useful in selecting an antibody fragment exhibiting a binding affinity and specificity to mesothelin (MSLN). Also disclosed herein are a recombinant antibody specific to MSLN, an immunoconjugate comprising the recombinant antibody, and uses thereof in treating cancers.
    Type: Application
    Filed: June 8, 2022
    Publication date: August 22, 2024
    Inventors: An-Suei YANG, Hung-Ju HSU, Chao-Ping TUNG, Chung-Ming YU, Chi-Yung CHEN, Hong-Sen CHEN, Yu-Chuan HUANG, Pei-Hsun TSAI, Szu-Yu LIN, Hung-Pin PENG
  • Patent number: 11784541
    Abstract: A grounding structure for a motor stator includes a silicon steel sheet unit, and upper and lower insulating frames clamping the silicon steel sheet unit therebetween. The grounding structure further includes a conductive member and a circuit board. The conductive member is clamped between the silicon steel sheet unit and the lower insulating frame, and protruding from a lower end of the lower insulating frame. The circuit board is disposed at a lower side of the lower insulating frame, and includes a negative contact that is connected to a lower edge of the conductive member.
    Type: Grant
    Filed: April 1, 2022
    Date of Patent: October 10, 2023
    Assignee: YEN SUN TECHNOLOGY CORP.
    Inventors: Graham Chen, Chih-Tsung Hsu, Hsin-Hsien Wu, Chin-Hui Pan, Yu-Chuan Huang
  • Publication number: 20230168249
    Abstract: Disclosed herein are recombinant antibodies or the fragment thereof for detecting severe acute respiratory syndrome coronavirus (SARS-CoV). According to some embodiments, the SARS-CoV is SARS-CoV-1. According to some alternative embodiments, the SARS-CoV is SARS-CoV-2. Also disclosed herein are a kit comprising the recombinant antibodies, and a method for diagnosing the infection of SARS-CoV by using the recombinant antibody or the kit.
    Type: Application
    Filed: May 4, 2021
    Publication date: June 1, 2023
    Applicant: Academia Sinica
    Inventors: An-Suei YANG, Chao-Ping TUNG, Chung-Ming YU, Chi-Yung CHEN, Yu-Chuan HUANG, Pei-Hsun TSAI, Szu-Yu LIN, Hung-Ju HSU, Hung-Pin PENG, Fei-Hung HUNG
  • Publication number: 20230133593
    Abstract: A grounding structure for a motor stator includes a silicon steel sheet unit, and upper and lower insulating frames clamping the silicon steel sheet unit therebetween. The grounding structure further includes a conductive member and a circuit board. The conductive member is clamped between the silicon steel sheet unit and the lower insulating frame, and protruding from a lower end of the lower insulating frame. The circuit board is disposed at a lower side of the lower insulating frame, and includes a negative contact that is connected to a lower edge of the conductive member.
    Type: Application
    Filed: April 1, 2022
    Publication date: May 4, 2023
    Inventors: Graham CHEN, Chih-Tsung HSU, Hsin-Hsien WU, Chin-Hui PAN, Yu-Chuan HUANG
  • Patent number: 9084798
    Abstract: A pharmaceutical composition for treating diabetes is provided in this invention. The composition contains a lanostane compound as a potent component. A suitable source of the lanostane compound is a Poria extract from metabolite, sclerotium, or fermentation product of Poria cocos (Schw) Wolf. The Poria extract contains 1-60% of the lanostane compounds by weight of the extract, and is devoid of secolanostane.
    Type: Grant
    Filed: August 10, 2010
    Date of Patent: July 21, 2015
    Assignee: Sinphar Tian-Li Pharmaceutical Co., Ltd (Hangzhou)
    Inventors: Hang-Ching Lin, Yu-Chuan Huang, Tsu-Chung Chang, Wen-Liang Chang
  • Patent number: 7947443
    Abstract: The electrical conductivity of DNA and other oligonucleotide constructs is dependent on its conformational state. Such a dependence may be harnessed for the electronic sensing of external analytes, for instance, adenosine or thrombin. Such a DNA sensor incorporates an analyte receptor, whose altered conformation in the presence of bound analyte switches the conformation, and hence, the conductive path between two oligonucleotide stems, such as double-helical DNA. Two distinct designs for such sensors are described that permit significant electrical conduction through a first or “detector” double-helical stem only in the presence of the bound analyte. In the first design, current flows through the analyte receptor itself whereas, in the second, current flows in a path adjacent to the receptor.
    Type: Grant
    Filed: April 14, 2008
    Date of Patent: May 24, 2011
    Assignee: Simon Fraser University
    Inventors: Dipankar Sen, Richard P. Fahlman, Hua Zhong Yu, Bixia Ge, Yu Chuan Huang
  • Publication number: 20110053899
    Abstract: A pharmaceutical composition for treating diabetes is provided in this invention. The composition contains a lanostane compound as a potent component. A suitable source of the lanostane compound is a Poria extract from metabolite, sclerotium, or fermentation product of Poria cocos (Schw) Wolf. The Poria extract contains 1-60% of the lanostane compounds by weight of the extract, and is devoid of secolanostane.
    Type: Application
    Filed: August 10, 2010
    Publication date: March 3, 2011
    Applicant: SINPHAR TIAN-LI PHARMACEUTICAL CO., LTD (HANGZHOU)
    Inventors: Hang-Ching Lin, Yu-Chuan Huang, Tsu-Chung Chang, Wen-Liang Chang
  • Publication number: 20090172504
    Abstract: The Viterbi decoder is an essential module in a communication system, in which the power and the decoding latency are restricted. In the present invention, a power efficient low latency survivor memory architecture and an operating method for the Viterbi decoder are disclosed by providing a plurality of trace-forward units, a plurality of first signal selecting units, a plurality of second signal selecting units and a third signal selecting unit to reduce the power consumption by decreasing the exchange times of contents in the trace-forward units. Thus, the present invention is suitable for use in mobile communication devices which require low power consumption.
    Type: Application
    Filed: November 18, 2008
    Publication date: July 2, 2009
    Applicant: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
    Inventors: Yu-Chuan Huang, Chun-Yuan Chu, An-Yu Wu
  • Publication number: 20080293160
    Abstract: The electrical conductivity of DNA and other oligonucleotide constructs is dependent on its conformational state. Such a dependence may be harnessed for the electronic sensing of external analytes, for instance, adenosine or thrombin. Such a DNA sensor incorporates an analyte receptor, whose altered conformation in the presence of bound analyte switches the conformation, and hence, the conductive path between two oligonucleotide stems, such as double-helical DNA. Two distinct designs for such sensors are described that permit significant electrical conduction through a first or “detector” double-helical stem only in the presence of the bound analyte. In the first design, current flows through the analyte receptor itself whereas, in the second, current flows in a path adjacent to the receptor.
    Type: Application
    Filed: April 14, 2008
    Publication date: November 27, 2008
    Applicant: SIMON FRASER UNIVERSITY
    Inventors: Dipankar SEN, Richard P. FAHLMAN, Yu Chuan HUANG, Hua Zhong YU, Bixia GE